Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. π€π
June 19, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ Neuroscience.
Knowledge Graph-Enhanced Deep Learning Model (H-SYSTEM) for Hypertensive Intracerebral Hemorrhage: Model Development and Validation.
AI-Driven H-SYSTEM Achieves 94.87% Accuracy in Hypertensive Intracerebral Hemorrhage Diagnosis π§ π
June 13, 2025
Economic implications of artificial intelligence-driven recommended systems in healthcare: a focus on neurological disorders.
AI in healthcare boosts efficiency, especially for neurological disorders. New models enhance cost-effectiveness and access. ππ§
June 5, 2025
Enhanced Early Brain Tumor Detection Crossing Blood-Brain Barrier through MRI Images Using Berkeley Wavelet-Transformation-Based Segmentation.
Enhanced brain tumor detection via MRI using Berkeley wavelet transformation shows improved accuracy and efficiency. π§ π
June 4, 2025
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π
May 21, 2025
Chipiron Secures $17 Million for Portable MRI Development
Chipiron raises $17 million for portable MRI development, aiming to enhance accessibility in local care centers and clinics. π₯π°
May 8, 2025
AI and Machine Learning Enhance Stroke Treatment to Minimize Disability
AI and machine learning are improving stroke treatment, aiming to reduce disability and enhance patient outcomes. π§ π‘
May 2, 2025
New AI Tool Assesses Treatment Efficacy for Multiple Sclerosis
New AI tool, MindGlide, assesses treatment effectiveness for multiple sclerosis using MRI scans. Promising advancements in patient care. π§ π‘
April 29, 2025
AI-assisted identification of disability patterns within identical EDSS grades.
AI reveals distinct disability patterns in MS with identical EDSS scores, enhancing clinical assessments. π€π
April 18, 2025
Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment.
Subacute Sclerosing Panencephalitis: SSPE’s global incidence, pathogenesis, and treatment options. π§ π
April 17, 2025